Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote Assessment of Lung Disease and Impact on Physical and Mental Health

NCT05630599 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05630599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05630599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote Assessment of Lung Disease and Impact on Physical and Mental Health
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
July 26, 2021
Completion date
March 31, 2023
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, covid19, interstitial lung disease